New Delhi, May 20 (PTI) The Central Drugs Laboratories have mentioned 60 drug samples of various firms to be "not of standard quality" in its monthly drug alert for April, Health Ministry officials said on Tuesday.

They also said the state drugs testing laboratories have identified 136 drug samples as not of standard quality.

Also Read | Delhi Weather Forecast Today, May 20: National Capital Records 41.8 Degrees Celsius, High Humidity.

A list of 'Not of Standard Quality (NSQ)' drugs is displayed on the Central Drugs Standard Control Organisation (CDSCO) portal each month under routine regulatory surveillance activity.

Officials said drug samples are identified as NSQ if they fail in one or more specified quality parameters.

Also Read | Kempaiah Somashekar New Manipur HC CJ: President Appoints Karnataka HC Judge as Chief Justice of Manipur High Court.

The failure is specific to the drug products of the batch tested by the government laboratory and it does not warrant any concerns on the other drug products available in the market, an official clarified.

In the April 2025 alert, one drug sample from Bihar was identified as spurious. It was manufactured by an unauthorised manufacturer using a brand name owned by another company, an official said, adding the matter was under investigation.

This action of identifying NSQ, misbranded and spurious medicines is taken on a regular basis in collaboration with state regulators to ensure that these drugs are identified and removed from of market.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)